Loading...

APC anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7_APC_091907
C57BL/6 mouse splenocytes stained with IM7 APC
  • IM7_APC_091907
    C57BL/6 mouse splenocytes stained with IM7 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103011 25 µg 27€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103012 100 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD44 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  2. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
  3. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  4. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  5. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  6. Pettini E, et al. 2021. Vaccines (Basel). 9:. PubMed
  7. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  8. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  9. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  10. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  11. Yan Y, et al. 2022. Cell Death Differ. 29:1769. PubMed
  12. Li Y, et al. 2022. J Exp Clin Cancer Res. 41:128. PubMed
  13. Campisi L, et al. 2022. Nature. 606:945. PubMed
  14. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  15. Xia KS, et al. 2023. Bioact Mater. 21:69. PubMed
  16. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  17. Liu M, et al. 2022. Cells. 11: . PubMed
  18. Cagle LA, et al. 2023. Front Physiol. 13:1059686. PubMed
  19. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  20. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  21. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  22. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  23. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  24. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  25. Che L, et al. 2023. Foods. 12:. PubMed
  26. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  27. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  28. Liu Y, et al. 2023. Cancers (Basel). 15:. PubMed
  29. Ben-Yaakov H, et al. 2023. Cancers (Basel). 15:. PubMed
  30. Tarafder S, et al. 2023. Bioact Mater. 28:61. PubMed
  31. Tai W, et al. 2023. Nat Commun. 14:2962. PubMed
  32. Yen FC, et al. 2023. Nat Commun. 14:2942. PubMed
  33. Hu Y, et al. 2023. JCI Insight. 8:. PubMed
  34. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  35. Kurosawa M, et al. 2021. Int J Mol Sci. 22:. PubMed
  36. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  37. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  38. Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed
  39. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  40. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  41. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  42. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  43. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  44. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  45. Nair N, et al. 2020. Curr Protoc Microbiol. 59:e127. PubMed
  46. Li J, et al. 2022. Int J Biol Sci. 18:2091. PubMed
  47. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  48. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  49. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  50. Limon JJ et al. 2019. Cell host & microbe. 25(3):377-388 . PubMed
  51. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  52. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  53. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
  54. Yasuoka T, et al. 2016. PLoS One. 11: 0157395. PubMed
  55. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  56. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  57. Voga M, et al. 2021. Front Vet Sci. 7:610240. PubMed
  58. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  59. Harada Y, et al. 2022. iScience. 25:104021. PubMed
  60. Liu H, et al. 2022. Nat Commun. 13:3684. PubMed
  61. Flaherty S, Reynolds J 2015. J Vis Exp. 98: 52739. PubMed
  62. Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed
  63. Sumigray KD et al. 2018. Developmental cell. 45(2):183-197 . PubMed
  64. Lo PK, et al. 2018. Elife. 7:e31334. PubMed
  65. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  66. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  67. Han Y, et al. 2019. Am J Cancer Res. 9:800. PubMed
  68. Arandjelovic S, et al. 2010. J Leukoc Biol. 88:737. PubMed
  69. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  70. Li J, et al. 2020. Cancer Discov. . PubMed
  71. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  72. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  73. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  74. Yin Q, et al. 2021. Proc Natl Acad Sci U S A. 118: . PubMed
  75. Skordos I, et al. 2021. STAR Protocols. 2(1):100351. PubMed
  76. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  77. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  78. Kim HR, et al. 2018. Nat Commun. 9:3630. PubMed
  79. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  80. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  81. Uhde A, et al. 2016. PLoS One. 11: 0161883. PubMed
  82. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  83. Florêncio KGD, et al. 2022. Front Immunol. 13:941757. PubMed
  84. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  85. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  86. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  87. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  88. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  89. Garhyan J, et al. 2015. Am J Pathol. 185: 1924-1934. PubMed
  90. Dai B, et al. 2012. Mol Ther. 20:1800. PubMed
  91. Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
  92. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  93. Daly CS, et al. 2018. Oncol Rep. 39:483. PubMed
  94. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  95. Kang DW, et al. 2020. J Pathol. 252:304. PubMed
  96. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  97. Clark GC, et al. 2022. Front Oncol. 12:913656. PubMed
  98. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  99. Long H, et al. 2022. Oncol Lett. 23:95. PubMed
  100. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  101. Naik A, et al. 2015. J Immunol. 194:790. PubMed
  102. Godavarthy PS, et al. 2019. Haematologica. 104(10). PubMed
  103. Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
  104. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  105. Cañadas I, et al. 2018. Nat Med. 24:1143. PubMed
  106. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  107. Xiao S, et al. 2020. Cell Reports. 32(2):107892. PubMed
  108. Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed
  109. Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
  110. Pastushenko I, et al. 2020. Nature. 589:448. PubMed
  111. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  112. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  113. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  114. Fei W, et al. 2022. Int J Stem Cells. :. PubMed
  115. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  116. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  117. Thakur A, et al. 2018. Front Immunol. 2.336805556. PubMed
  118. Jimenez H, et al. 2019. EBioMedicine. 44:209. PubMed
  119. Revathikumar P, et al. 2018. PLoS One. 13:e0193210. PubMed
  120. Magness S, et al. 2013. Am J Physiol Gastrointest Liver Physiol. 305:542. PubMed
  121. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  122. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  123. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  124. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  125. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  126. Shissler SC, et al. 2020. Sci Rep. 10:8218. PubMed
  127. Yamazaki M, et al. 2021. Biomedicines. 9:. PubMed
  128. Jeljeli M, et al. 2021. Front Immunol. 12:670776. PubMed
  129. Tian Q, et al. 2022. Cell Death Dis. 13:71. PubMed
  130. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  131. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  132. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  133. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  134. Lau J, et al. 2015. Cancer Res . 75: 4302 - 4311. PubMed
  135. Hwang WL, et al. 2019. J Hematol Oncol. 12:10. PubMed
  136. Kobayashi A, et al. 2011. J Exp Med. 208:2641. PubMed
  137. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  138. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  139. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  140. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  141. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  142. Mizuno M, et al. 2021. Cancers (Basel). 13:. PubMed
  143. Norgard RJ, et al. 2021. EMBO Rep. 22:e51872. PubMed
  144. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  145. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  146. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  147. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  148. Gejman RS et al. 2018. eLife. 7 pii: e41090. PubMed
  149. Weber K, et al. 2008. J Immunol. 180:1442. PubMed
  150. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  151. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  152. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  153. Gawish R, et al. 2022. Elife. 11:. PubMed
  154. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  155. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  156. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  157. Wang W, et al. 2022. Oxid Med Cell Longev. 2022:8172866. PubMed
  158. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
  159. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  160. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  161. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  162. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
RRID
AB_312962 (BioLegend Cat. No. 103011)
AB_312962 (BioLegend Cat. No. 103012)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark Red™ 718 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Go To Top Version: 2    Revision Date: 09-11-2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account